CLINICAL_TRIALS
trial_result
· 2023-11-29
Clinical Trial Update: Study of Daratumumab in Patients With Mild to Moderate Alzheimer's Disease [Phase 2]
Summary
A Phase 2 trial evaluating daratumumab in patients with mild to moderate Alzheimer's disease has been completed and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Marc L Gordon, MD | Conditions: Alzheimer Disease | Phase 2 | Status: COMPLETED | Results posted: 2023-11-29